Category: St. Jude MedicalSyndicate content

Medtech trends: The most talked about device makers in February 2014

March 4, 2014 by Arezu Sarvestani

MassDevice.com looks at the internet chatter surrounding the medical device industry with some of most searched-for companies of the last month.

chart

Click to enlarge.

MassDevice.com looked at some of the most talked-about medical device companies, based on trends in U.S. Google searches for the last 30 days.

Volcano loses round in FFR war with St. Jude Medical

March 3, 2014 by Brad Perriello

Volcano agrees that St. Jude Medical isn't infringing a pair of its fractional flow reserve patents after a court ruling doesn't go its way, but vows to appeal.

Volcano loses round in FFR war with St. Jude Medical
Volcano loses round in FFR war with St. Jude Medical

J&J's Biosense Webster wins PMA nod from FDA for force-sensing catheter

February 25, 2014 by Brad Perriello

Johnson & Johnson's Biosense Webster subsidiary is the 1st to the U.S. market with a force-sensing ablation catheter for atrial fibrillation, the ThermoCool SmartTouch device.

J&J's Biosense Webster wins PMA nod from FDA for force-sensing catheter

Johnson & Johnson's (NYSE:JNJ) Biosense Webster subsidiary said it won pre-market approval from the FDA for its ThermoCool SmartTouch force-sensing ablation catheter, making it the 1st such device to hit the U.S. market.

St. Jude Medical warns docs on electrocautery risk with older pacemaker models

February 21, 2014 by Brad Perriello

St. Jude Medical warns physicians of a potential problem with its older pacemaker models when performing electrocautery procedures.

St. Jude Medical warns docs on electrocautery risk with older pacemaker models

St. Jude Medical (NYSE:STJ) sent a letter to physicians late last month warning of the potential for problems with its older pacemakers during surgical procedures using electrocautery.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Medtronic touts 1st U.S. implantation in Micra leadless pacemaker trial

February 20, 2014 by Brad Perriello

Medtronic touts the 1st U.S. implantation in the investigational device exemption trial of its Micra leadless pacemaker.

Medtronic touts 1st U.S. implantation in Micra leadless pacemaker trial

Medtronic (NYSE:MDT) said the 1st patient in a clinical trial of its its Micra pacemaker was implanted with the vitamin-sized device, which does not use wires threaded through blood vessels to regulate heart rhythm.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Is Medtronic losing CRM share to Boston Scientific, St. Jude?

February 19, 2014 by Brad Perriello

Medtronic's most recent quarterly results suggest that the medtech monolith could be losing ground to arch-rivals Boston Scientific and St. Jude Medical in the cardiac rhythm management market.

Is Medtronic losing CRM share to Boston Scientific, St. Jude?

Revenues from Medtronic's (NYSE:MDT) bread-and-butter cardiac rhythm management and spine segments were down during its fiscal 3rd quarter, suggesting that the world's largest pure-play medical device maker lost share to its rivals during the quarter.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp